Videos

Table of contents:

Symposium Intensivmedizin + Intensivpflege -
11. - 13. Februar 2026

Angiotensin II (Giapreza®) in der Schockbehandlung:
Von der Pathophysiologie zur klinischen Anwendung

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Agenda

Opening of the symposium

Chair: Prof. Dr. Alexander Zarbock, Münster
Timestamp: 0min:00sec

Die Störung des Renin-Angiotensin-Systems im Schock

Speaker: Prof. Dr. Alexander Zarbock, Universitätsklinikum Münster
Timestamp: 2min:00sec

Angiotensin II bei akutem Nierenversagen im distributiven Schock

Speaker: Prof. Dr. Marlies Ostermann, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Timestamp: 21min:30sec

Angiotensin II konkret – Fallbeispiele aus Sepsis und gemischten Schockformen

Speaker: Dr. Alexander Kersten, Uniklinik RWTH Aachen
Timestamp: 35min:55sec

Remimazolam (Byfavo®) in vulnerable patients: New Evidence and Clinical Insights

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Agenda

Opening of the symposium

Chair: Prof. Dr. Peter Tonner, Leer
Timestamp: 0min:00sec

Remimazolam: Pharmacology and evidence for the use in frail and elderly patients

Speaker: Prof. Dr. Peter Tonner, Klinikum Leer, Germany
Timestamp: 2min:10sec

Remimazolam anesthesia in vulnerable patients: Insights from clinical practice

Speaker: Dr. Lucas van Eijk, Radboud UMC, Nijmegen, the Netherlands
Timestamp: 22min:50sec

Remimazolam sedation for cardiac ablation: Insights from a randomized controlled trial

Speaker: Dr. Marek Hozman, University Hospital Královské Vinohrady, Prague, Czech Republic
Timestamp: 39min:25sec

DIVI 2025 - PAION Pharma Symposium

Symposium: Real World Evidence with
Angiotensin II GIAPREZA®

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Agenda

Opening of the Symposium

Chair: Dr. Daniel Leisman (Harvard Medical School and Massachusetts General Hospital, Boston, USA)
Timestamp: 0min:00sec

Angiotensin II – Why? When? How?
The Slovenian experience

Speaker: Dr. Andrej Markota (University Medical
Centre Maribor, Maribor, Slovenia)
Timestamp: 1min:50sec

Angiotensin II and precision vasopressor therapy: Act early and AIMRITE –
the US experience

Speaker: Dr. Daniel Leisman
Timestamp: 16min:00sec

Case reports on the use of Angiotensin II in refractory shock – the German experience

Speaker: PD Dr. Christina Scharf-Janßen (Ludwig Maximilian University (LMU) Hospital, Munich, Germany)
Timestamp: 39min:30sec
Timestamp: 52min:50sec (Q&A Session)

DGAI 2025 - Annual Congress in Kassel

DGAI 2025 - PAION Pharma Symposium (presentations in German)

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Agenda

Opening of the symposium

Chair: Prof. Dr. med. Jörg Fechner (Erlangen)
Timestamp: 0min:00sec

Remimazolam: a new sedative
with innovative pharmacokinetics and
pharmacodynamics

Speaker: Prof. Dr. med. Jörg Fechner (Erlangen)
Timestamp: 0min:40sec

Remimazolam for anesthesia

Speaker: PD Dr. med. Ana Kowark (Bonn)
Timestamp: 18min:50sec

Remimazolam for short-term sedation + Q&A session

Speaker: Prof. Dr. med. Dominik Günsch (Bern)
Timestamp: 33min:40sec
Timestamp: 50min:50sec (Q&A Session)

Euroanaesthesia 2025 - Lisbon

Remimazolam – European and Global Perspectives in 2025
Sponsored by PAION Pharma

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Agenda

Opening of the Symposium

Chair: Tomislav Radocaj (Croatia)
Timestamp: 0min:00sec

Reflections on Remimazolam

Speaker: Tomislav Radocaj (Croatia)
Timestamp: 0min:55sec

Remimazolam: The Chinese Experience

Speaker: Jin Liu (China)
Timestamp: 14min:50sec

Remimazolam: A European Perspective

Speaker: Lucas van Eijk (Netherlands)
Timestamp: 30min:20sec

Q&A Session

Timestamp: 44min:50sec

International Symposium on Intensive Care and Emergency Medicine 2025

Optimizing Vasopressor Strategies: Clinical Advances with Angiotensin II

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Symposium Intensive Medicine + Intensive Care - 12 - 14 February 2025

Prof. Dr. med. Peter H. Tonner:
‘Angiotensin II: state of affairs - what does the literature say?’

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

PD Dr Ulf Günther:
‘How do I use angiotensin II?’

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Jan Fest, MD: ‘Angiotensin II: A Case Report’

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Angiotensin II (Giapreza®) in der Schockbehandlung:
Von der Pathophysiologie zur klinischen Anwendung

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Agenda

Opening of the symposium

Chair: Prof. Dr. Alexander Zarbock, Münster
Timestamp: 0min:00sec

Die Störung des Renin-Angiotensin-Systems im Schock

Speaker: Prof. Dr. Alexander Zarbock, Universitätsklinikum Münster
Timestamp: 2min:00sec

Angiotensin II bei akutem Nierenversagen im distributiven Schock

Speaker: Prof. Dr. Marlies Ostermann, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Timestamp: 21min:30sec

Angiotensin II konkret – Fallbeispiele aus Sepsis und gemischten Schockformen

Speaker: Dr. Alexander Kersten, Uniklinik RWTH Aachen
Timestamp: 35min:55sec

Scroll to Top